| Record ID | ia:enzymeprodrugstr0000unse |
| Source | Internet Archive |
| Download MARC XML | https://archive.org/download/enzymeprodrugstr0000unse/enzymeprodrugstr0000unse_marc.xml |
| Download MARC binary | https://www.archive.org/download/enzymeprodrugstr0000unse/enzymeprodrugstr0000unse_meta.mrc |
LEADER: 01352cam a2200361 a 4500
001 98037682
003 DLC
005 20080310103553.0
008 980911s1999 nyua b 001 0 eng c
010 $a 98037682
020 $a0306458950
040 $aDNLM/DLC$cDLC$dDLC
050 10 $aRC271.A66$bE56 1998
060 10 $aQZ 267$bE61 1998
082 00 $a616.99/4061$221
245 00 $aEnzyme-prodrug strategies for cancer therapy /$cedited by Roger G. Melton and Richard J. Knox.
260 $aNew York :$bKluwer Academic/Plenum Publishers,$cc1999.
300 $axiii, 257 p. :$bill. ;$c24 cm.
504 $aIncludes bibliographical references and index.
650 0 $aAntibody-directed enzyme prodrug therapy.
650 0 $aCancer$xChemotherapy.
650 0 $aProdrugs.
650 0 $aAntibody-enzyme conjugates$xTherapeutic use.
650 12 $aAntineoplastic Agents$xtherapeutic use.
650 12 $aProdrugs$xtherapeutic use.
650 22 $aNeoplasms$xdrug therapy.
650 22 $aAntibodies$xtherapeutic use.
650 22 $aEnzymes$xtherapeutic use.
650 22 $aAntigens$xdrug effects.
700 1 $aMelton, Roger G.
700 1 $aKnox, Richard J.
856 42 $3Publisher description$uhttp://www.loc.gov/catdir/enhancements/fy0819/98037682-d.html
856 41 $3Table of contents only$uhttp://www.loc.gov/catdir/enhancements/fy0819/98037682-t.html